Bluestar Adisseo Company (SHA:600299)

Market Cap	40.93B +44.4%
Revenue (ttm)	17.33B +6.1%
Net Income	995.25M -28.5%
EPS	0.36 -31.0%
Shares Out	3.08B
PE Ratio	36.96
Forward PE	n/a
Dividend	0.15 (1.14%)
Ex-Dividend Date	Feb 27, 2026

Volume	31,362,059
Average Volume	25,848,290
Open	13.89
Previous Close	14.30
Day's Range	13.07 - 13.89
52-Week Range	8.66 - 16.48
Beta	0.41
RSI	45.83
Earnings Date	Apr 30, 2026

About Bluestar Adisseo Company

Bluestar Adisseo Company, together with its subsidiaries, engages in the research, development, production, and sale of poultry, ruminant, swine, and aquaculture nutrition additives. The company also offers mycotoxin management and palatability comprising, Unike Plus, Unike, Oxy-Nil, Mold-Nil, Salmo-Nil, Toxy-Nil, Krave AP, Optisweet, Gusti Plus, Maxarome, Delistart, Pepsea, Nutri-Bind Aqua, and Oxy-Nil Aqua Zero; enzymes and emulsifiers, including Rhodimet AT88 and Rhodimet; antioxidants and health by nutrition products, comprising Rhodimet AT...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1939
• Employees: 3,295
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600299

Financial Performance

In 2025, Bluestar Adisseo Company's revenue was 17.23 billion, an increase of 10.92% compared to the previous year's 15.53 billion. Earnings were 1.15 billion, a decrease of -4.13%.